Literature DB >> 20934972

Role of pancreatic stellate cells in pancreatic cancer metastasis.

Zhihong Xu1, Alain Vonlaufen, Phoebe A Phillips, Eva Fiala-Beer, Xuguo Zhang, Lu Yang, Andrew V Biankin, David Goldstein, Romano C Pirola, Jeremy S Wilson, Minoti V Apte.   

Abstract

Pancreatic stellate cells (PSCs) produce the stromal reaction in pancreatic cancer (PC), and their interaction with cancer cells facilitates cancer progression. This study investigated the role of human PSCs (hPSCs) in the metastatic process and tumor angiogenesis using both in vivo (orthotopic model) and in vitro (cultured PSC and PC cells) approaches. A sex mismatch study (injection of male hPSCs plus female PC cells into the pancreas of female mice) was conducted to determine whether hPSCs accompany cancer cells to metastatic sites. Metastatic nodules were examined by fluorescent in situ hybridization for the presence of the Y chromosome. Angiogenesis was assessed by i) immunostaining tumors for CD31, an endothelial cell marker; and ii) quantifying human microvascular endothelial cell (HMEC-1) tube formation in vitro on exposure to conditioned media from hPSCs. Transendothelial migration was assessed in vitro by examining the movement of fluorescently labeled hPSCs through an endothelial cell monolayer. Human PSCs i) were found in multiple metastatic sites in each mouse injected with male hPSCs plus female PC cells; ii) increased CD31 expression in primary tumors from mice injected with MiaPaCa-2 and hPSCs and stimulated tube formation by HMEC-1 in vitro; and iii) exhibited transendothelial migration that was stimulated by cancer cells. Human PSCs accompany cancer cells to metastatic sites, stimulate angiogenesis, and are able to intravasate/extravasate to and from blood vessels.

Entities:  

Mesh:

Year:  2010        PMID: 20934972      PMCID: PMC2966814          DOI: 10.2353/ajpath.2010.090899

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Authors:  Daruka Mahadevan; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2007-04-03       Impact factor: 6.261

Review 2.  Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Endocr Rev       Date:  2007-04-04       Impact factor: 19.871

Review 3.  Inhibition of angiogenesis in the treatment of non-small cell lung cancer.

Authors:  Vicki L Keedy; Alan B Sandler
Journal:  Cancer Sci       Date:  2007-09-24       Impact factor: 6.716

Review 4.  The integrin-extracellular matrix axis in pancreatic cancer.

Authors:  John J Grzesiak; Jason C Ho; Abdool R Moossa; Michael Bouvet
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

5.  Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment.

Authors:  Lars Mueller; Freya A Goumas; Marianne Affeldt; Susanne Sandtner; Ursula M Gehling; Silke Brilloff; Jessica Walter; Nadia Karnatz; Katrin Lamszus; Xavier Rogiers; Dieter C Broering
Journal:  Am J Pathol       Date:  2007-10-04       Impact factor: 4.307

6.  The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling.

Authors:  Takao Ide; Yoshihiko Kitajima; Atsushi Miyoshi; Takao Ohtsuka; Mayumi Mitsuno; Kazuma Ohtaka; Kohji Miyazaki
Journal:  Ann Surg Oncol       Date:  2007-05-30       Impact factor: 5.344

7.  Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.

Authors:  Marina Marchetti; Alfonso Vignoli; Laura Russo; Donatella Balducci; Marcella Pagnoncelli; Tiziano Barbui; Anna Falanga
Journal:  Thromb Res       Date:  2007-08-10       Impact factor: 3.944

8.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

Authors:  Rosa F Hwang; Todd Moore; Thiruvengadam Arumugam; Vijaya Ramachandran; Keith D Amos; Armando Rivera; Baoan Ji; Douglas B Evans; Craig D Logsdon
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

9.  Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas.

Authors:  Veera Näyhä; Frej Stenbäck
Journal:  APMIS       Date:  2008-02       Impact factor: 3.205

10.  Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.

Authors:  Michaël Peyromaure; Cécile Badoual; Philippe Camparo; Sophie Grabar; Claire Goulvestre; Yvonne Fulla; Annick Vieillefond; Kaili Mao; Anh-Tuan Dinh-Xuan
Journal:  Oncol Rep       Date:  2007-07       Impact factor: 3.906

View more
  136 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Response.

Authors:  David Goldstein; Daniel Von Hoff
Journal:  J Natl Cancer Inst       Date:  2015-08-06       Impact factor: 13.506

3.  Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.

Authors:  Yuanke Li; Zhen Zhao; Hao Liu; John Peter Fetse; Akshay Jain; Chien-Yu Lin; Kun Cheng
Journal:  ACS Appl Mater Interfaces       Date:  2019-11-26       Impact factor: 9.229

4.  Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer.

Authors:  Dong Tang; Jun Gao; Sen Wang; Zhongxu Yuan; Nianyuan Ye; Yang Chong; Chuanqi Xu; Xuetong Jiang; Bin Li; Wei Yin; Yi Miao; Daorong Wang; Kuirong Jiang
Journal:  Tumour Biol       Date:  2015-03-01

5.  Development of photoactive Sweet-C60 for pancreatic cancer stellate cell therapy.

Authors:  Maciej Serda; Matthew J Ware; Jared M Newton; Sanchit Sachdeva; Martyna Krzykawska-Serda; Lam Nguyen; Justin Law; Andrew O Anderson; Steven A Curley; Lon J Wilson; Stuart J Corr
Journal:  Nanomedicine (Lond)       Date:  2018-12-03       Impact factor: 5.307

6.  Malignant cells facilitate lung metastasis by bringing their own soil.

Authors:  Dan G Duda; Annique M M J Duyverman; Mitsutomo Kohno; Matija Snuderl; Ernst J A Steller; Dai Fukumura; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 7.  Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.

Authors:  Stacey J Coleman; Jennifer Watt; Prabhu Arumugam; Leonardo Solaini; Elisabeta Carapuca; Mohammed Ghallab; Richard P Grose; Hemant M Kocher
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 8.  COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.

Authors:  Fernando Vázquez-Villa; Marcos García-Ocaña; José A Galván; Jorge García-Martínez; Carmen García-Pravia; Primitiva Menéndez-Rodríguez; Carmen González-del Rey; Luis Barneo-Serra; Juan R de Los Toyos
Journal:  Tumour Biol       Date:  2015-03-12

9.  Generation of an in vitro 3D PDAC stroma rich spheroid model.

Authors:  Matthew J Ware; Vazrik Keshishian; Justin J Law; Jason C Ho; Carlos A Favela; Paul Rees; Billie Smith; Sayeeduddin Mohammad; Rosa F Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean P Edwards; Stuart J Corr; Biana Godin; Steven A Curley
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

Review 10.  Triggering the landslide: The tumor-promotional effects of myofibroblasts.

Authors:  Christine Mehner; Derek C Radisky
Journal:  Exp Cell Res       Date:  2013-03-22       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.